Ronald F. Tutrone, Jr., MD, FACS, CPI, Author at Grand Rounds in Urology

Ronald F. Tutrone, Jr., MD, FACS, CPI

Chesapeake Urology

Towson, Maryland

Dr. Tutrone is Chief of Urology and Chairman of the William E. Kahlert Endowment for Urological Research at the Greater Baltimore Medical Center in Towson, Maryland. He also serves as Medical Director of both Chesapeake Urology Research Associates and the Chesapeake Urology Infusion Therapy Center. Dr. Tutrone’s clinical interests include treatment of urologic malignancies including kidney, bladder, and prostate; laparoscopic treatment of renal and adrenal tumors; kidney stone treatment; urinary incontinence in men and women; and prostate disorders. He also performs the UroLift procedure for the treatment of BPH/enlarged prostate. He has been voted a “Top Doctor” by Baltimore Magazine numerous times, and a “Super Doctor” for Urology in the Washington Post Magazine. Dr. Tutrone has authored numerous articles and has been principal investigator in more than 200 clinical research trials.

Disclosures:

Talks by Ronald F. Tutrone, Jr., MD, FACS, CPI

Fexapotide for BPH

Posted by Ronald F. Tutrone, Jr., MD, FACS, CPI | May 2018

Ronald F. Tutrone, Jr., MD, FACS, summarizes two Phase III clinical trials testing the safety and efficacy of fexapotide, a novel treatment for benign prostatic hyperplasia (BPH).

Ronald F. Tutrone, Jr., MD, FACS, CPI

Chesapeake Urology

Towson, Maryland

Talks by Ronald F. Tutrone, Jr., MD, FACS, CPI

Fexapotide for BPH

Join the GRU Community

You have Successfully Subscribed!